ALAnnemarie L. Lee

Annemarie L. Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Annemarie L. Lee has a total of 46 co-authors. Here are the top co-authors by number of shared publications:

  • Dina Brooks

    Department of Respiratory Medicine, West Park Healthcare Centre, Toronto, ON, Canada; Department of Physical Therapy, University of Toronto, Toronto, ON, Canada

    3 shared publications
  • Anne Elizabeth Holland

    Respiratory Research@Alfred, Monash University, Melbourne, Australia; Physiotherapy, Alfred Health, Melbourne, Australia; Institute for Breathing and Sleep, Melbourne, Australia

    2 shared publications
  • Matthew Rhim

    Department of Respiratory Medicine, West Park Healthcare Centre, Toronto, ON, Canada

    2 shared publications
  • Roger S. Goldstein

    Department of Respiratory Medicine, West Park Healthcare Centre, Toronto, ON, Canada; Department of Physical Therapy, University of Toronto, Toronto, ON, Canada; Department of Medicine, University of Toronto, Toronto, ON, Canada

    2 shared publications
  • Angela T Burge

    Department of Rehabilitation, Nutrition and Sport, School of Allied Health, La Trobe University Discipline of Physiotherapy Plenty Road and Kingsbury Drive Melbourne Australia

    1 shared publication
  • Anne Chang

    Australian Bronchiectasis Registry Australia

    1 shared publication

Latest Publications

  • The educational needs of people with bronchiectasis in a pulmonary rehabilitation setting

    by Annemarie Lee, Rebecca Smith, Christian Osadnik, Lucy Burr, Anne Chang, Chien-Li Holmes-Liew, Lata Jayaram, Paul King, Peter Middleton, Lucy Morgan, et al.

    Introduction: Pulmonary rehabilitation is recommended for people with bronchiectasis, but the content for an educational program is not directed towards people with this condition. The goal of the qualitative study was to identify the educational needs of people with bronchiectasis in a pulmonary rehabilitation setting. Methods: A qualitative study of people with bronchiectasis, registered on the Australian Bronchiectasis Registry using individual semi-structured interviews was undertaken. Transcripts were coded independently by two investigators and themes developed through consensus. Results: A total of 21 people with bronchiectasis (mean age 72±11 years, FEV1 83.1±25.4% predicted) participated in an interview. Participants indicated they have a good understanding of their condition, which factors may increase risk of an acute exacerbation, their medications and that physiotherapy is an important part of treatment. Major themes for which further education was sought were the scope of airway clearance therapy options, methods of maintaining motivation for physiotherapy, coping strategies for psychosocial symptoms, and how to self-manage their condition. Participants perceived benefit in receiving information in a group setting. Conclusions: Unmet education needs of people with bronchiectasis include options for airway clearance therapy, development of coping strategies to manage the psychosocial challenges of the condition and self-management. This may provide a foundation for the development of structured education sessions that could be delivered within pulmonary rehabilitation for this population.

  • Open Access

    Multimorbidity rehabilitation versus disease-specific rehabilitation in people with chronic diseases: a pilot randomized controlled trial

    by Kathryn Barker, Anne E. Holland, Annemarie L. Lee, Terry Haines, Kathryn Ritchie, Claire Boote, Joanne Saliba, Stephanie Lowe, Fiona Pazsa, Lee Thomas, et al.

    Multimorbidity (the co-existence of two or more chronic conditions in an individual) is a growing healthcare burden internationally; however, healthcare and disease management, including rehabilitation, is often delivered in single-disease siloes. The aims of this study were to (1) evaluate the safety and feasibility of multimorbidity rehabilitation compared to a disease-specific rehabilitation program in people with multimorbidity and (2) gather preliminary data regarding clinical outcomes and resource utilization to inform the design of future trials. A pilot feasibility randomized controlled trial with concealed allocation, assessor blinding, and intention-to-treat analysis. Seventeen individuals with a chronic disease eligible for disease-specific rehabilitation (pulmonary, cardiac, heart failure rehabilitation) and at least one other chronic condition were recruited. The intervention group attended multimorbidity exercise rehabilitation and the control group attended disease-specific exercise rehabilitation. Participants attended twice-weekly exercise training and weekly education for 8 weeks. Feasibility measures included numbers screened, recruited, and completed. Other outcome measures were change in functional exercise capacity (6-minute walk test (6MWT)), health-related quality of life (HRQoL), activities of daily living (ADL), and resource utilization. Sixty-one people were screened to recruit seventeen participants (nine intervention, eight control); one withdrew prior to rehabilitation. Participants were mostly male (63%) with a mean (SD) age of 69 (9) years and body mass index of 29 (6). The intervention group attended a mean (SD) of 12 (6) sessions, and the control group attended 11 (4) sessions. One participant (6%) withdrew after commencing; two (12%) were lost to follow-up. The intervention group 6MWT distance increased by mean (SD) of 22 (45) meters (95% confidence interval − 16 to 60) compared to 22 (57) meters (95% confidence interval − 69 to 114) (control). It was feasible to recruit people with multimorbidity to a randomized controlled trial of rehabilitation. A large RCT with the power to make significant conclusions about the impact on the primary and secondary outcomes is now required. The trial was registered with the Australian and New Zealand Clinical Trials Registry available at http://www.anzctr.org.au ACTRN12614001186640 . Registered 12/11/2014.


  • The Impact of Listening to Music During a High-Intensity Exercise Endurance Test in People With COPD

    by Annemarie L. Lee, Thomas E. Dolmage, Matthew Rhim, Roger S. Goldstein, Dina Brooks


  • Postural deviations in individuals with chronic obstructive pulmonary disease (COPD)

    by Annemarie L. Lee, Roger S. Goldstein, Christen Chan, Matthew Rhim, Karl Zabjek, Dina Brooks

    RATIONALE: While upper back pain in chronic obstructive pulmonary disease (COPD) suggests that postural dysfunction is a potential cause, the extent of postural deviation in COPD is unknown. OBJECTIVE: This study compared postural measurements in people with COPD to healthy controls and explored the relationship between posture deviations and pain in COPD. METHODS: Participants with COPD and age, gender, BMI and comorbidity-matched healthy controls. Participants underwent a postural geometric measurement in upright standing. 3-D motion analysis generated the coordinates of skeletal structures from anatomical landmarks. Participants with COPD completed questionnaires related to pain. Postural stability measures of center of pressure in the anteroposterior (A/P) and mediolateral (M/L) directions, spinal alignment, thoracic kyphosis, scapula and sternal orientation were completed. RESULTS: Twenty-one participants with COPD and 21 matched controls completed the study. The method of postural stability and alignment demonstrated excellent reliability in both groups (all ICC > 0.75). Those with COPD had a trend towards a greater center of pressure M/L sway compared to controls (mean 4.3 cm vs 2.9 cm), with no difference in center of pressure A/P sway. Thoracic kyphosis was greater in COPD (51.8° vs 39.1°, p = 0.001), but there was no difference in spinal alignment (p > 0.05). Those with COPD had an increase in left (p = 0.003) and right (p = 0.002) scapula protraction. Increased thoracic kyphosis and altered scapula position were unrelated to back pain in COPD (all p > 0.05). CONCLUSIONS: Postural deviations are evident in COPD, but the small number of those with pain limited analysis of the association between postural deviations and pain.


  • Smoking-Related Stigma Expressed by Physiotherapists toward Individuals with Lung Disease

    by Bethany Bass, Elizabeth Lake, Chelsea Elvy, Sarah Fodemesi, Mara Iacoe, Emilie Mazik, Dina Brooks, Annemarie Lee

    Purpose: We determined the extent and nature of stigma exhibited by a sample of Canadian cardiorespiratory physiotherapists toward people with lung disease who had a smoking history. Method: A quantitative online survey was distributed to Canadian cardiorespiratory physiotherapists, and an anti-smoking attitudes questionnaire was used to measure explicit stigma. We used two case studies with questions to measure implicit stigma. The first involved a patient with chronic obstructive pulmonary disease (COPD) and a smoking history, and the second described a patient with COPD with no smoking history. Results: Of the respondents (n=50), 56% demonstrated mild explicit stigma and 44% demonstrated moderate to severe explicit stigma. The extent of explicit stigma was not associated with respondents' age, area of practice, personal smoking history, or family history of lung disease resulting from smoking. The results indicated no evidence of implicit stigma, and no significant differences were found between the participants' prospective treatments and their professional attitudes toward patient cases. Conclusions: Canadian cardiorespiratory physiotherapists demonstrated explicit stigma toward people with lung disease with a significant smoking history, but there was no evidence of implicit stigma. These findings suggest that further research is needed to investigate how stigma held by cardiorespiratory physiotherapists may affect the quality of care provided for patients with a smoking history.


  • Pulmonary Rehabilitation in Bronchiectasis

    by Annemarie L. Lee, Anne E. Holland

  • Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis

    by Annemarie L Lee, Angela T Burge, Anne E Holland

    People with bronchiectasis experience chronic cough and sputum production and require the prescription of airway clearance techniques (ACTs). A common type of ACT prescribed is positive expiratory pressure (PEP) therapy. A previous review has suggested that ACTs including PEP therapy are beneficial compared to no treatment in people with bronchiectasis. However, the efficacy of PEP therapy in a stable clinical state or during an acute exacerbation compared to other ACTs in bronchiectasis is unknown. The primary aim of this review was to determine the effects of PEP therapy compared with other ACTs on health-related quality of life (HRQOL), rate of acute exacerbations, and incidence of hospitalisation in individuals with stable or an acute exacerbation of bronchiectasis. Secondary aims included determining the effects of PEP therapy upon physiological outcomes and clinical signs and symptoms compared with other ACTs in individuals with stable or an acute exacerbation of bronchiectasis. We searched the Cochrane Airways Group Specialised Register of Trials, PEDro and clinical trials registries from inception to February 2017 and we handsearched relevant journals. Randomised controlled parallel and cross-over trials that compared PEP therapy versus other ACTs in participants with bronchiectasis. We used standard methodological procedures as outlined by Cochrane. Nine studies involving 213 participants met the inclusion criteria, of which seven were cross-over in design. All studies included adults with bronchiectasis, with eight including participants in a stable clinical state and one including participants experiencing an acute exacerbation. Eight studies used oscillatory PEP therapy, using either a Flutter or Acapella device and one study used Minimal PEP therapy. The comparison intervention differed between studies. The methodological quality of studies was poor, with cross-over studies including suboptimal or no washout period, and a lack of blinding of participants, therapists or personnel for outcome measure assessment in most studies. Clinical heterogeneity between studies limited meta-analysis. Daily use of oscillatory PEP therapy for four weeks was associated with improved general health according to the Short-Form 36 questionnaire compared to the active cycle of breathing technique (ACBT). When applied for three sessions over one week, minimal PEP therapy resulted in similar improvement in cough-related quality of life as autogenic drainage (AD) and L'expiration Lente Totale Glotte Ouverte en Decubitus Lateral (ELTGOL). Oscillatory PEP therapy twice daily for four weeks had similar effects on disease-specific HRQOL (MD -0.09, 95% CI -0.37 to 0.19; low-quality evidence). Data were not available to determine the incidence of hospitalisation or rate of exacerbation in clinically stable participants. Two studies of a single session comparison of oscillatory PEP therapy and gravity-assisted drainage (GAD) with ACBT had contrasting findings. One study found a similar sputum weight produced with both techniques (SMD 0.54g (-0.38 to 1.46; 20 participants); the other found greater sputum expectoration with GAD and ACBT (SMD 5.6 g (95% CI 2.91 to 8.29: 36 participants). There was no difference in sputum weight yielded between oscillatory PEP therapy and ACBT with GAD when applied daily for four weeks or during an acute exacerbation. Although a single session of oscillatory PEP therapy was associated with less sputum compared to AD (median difference 3.1 g (95% CI 1.5 to 4.8 g; one study, 31 participants), no difference between oscillatory PEP therapy and seated ACBT was evident. PEP therapy had a similar effect on dynamic and static measures of lung volumes and gas exchange as all other ACTs. A single session of oscillatory PEP therapy (Flutter) generated a similar level of fatigue as ACBT with GAD, but greater fatigue was noted with oscillatory PEP therapy compared to ACBT alone. The degree of breathlessness experienced with PEP therapy did not differ from other techniques. Among studies exploring adverse events, only one study reported nausea with use of oscillatory PEP therapy. PEP therapy appears to have similar effects on HRQOL, symptoms of breathlessness, sputum expectoration, and lung volumes compared to other ACTs when prescribed within a stable clinical state or during an acute exacerbation. The number of studies and the overall quality of the evidence were both low. In view of the chronic nature of bronchiectasis, additional information is needed to establish the long-term clinical effects of PEP therapy over other ACTs for outcomes that are important to people with bronchiectasis and on clinical parameters which impact on disease progression and patient morbidity in individuals with stable bronchiectasis. In addition, the role of PEP therapy during an acute exacerbation requires further exploration. This information is necessary to provide further guidance for prescription of PEP therapy for people with bronchiectasis.


  • Open Access

    The Bronchiectasis Toolbox—A Comprehensive Website for the Management of People with Bronchiectasis

    by Caroline H. Nicolson, Anne E. Holland, Annemarie L. Lee

    While the health burden of bronchiectasis is increasing worldwide, medical and physiotherapy treatment strategies have progressed significantly over the past decade. For this reason, clinicians require readily accessible current evidence based information on the management of this condition. E-learning is a suitable educational forum for the development and maintenance of professional skills, however a comprehensive, evidence based, multidisciplinary website for bronchiectasis was not available. The Bronchiectasis Toolbox at www.bronchiectasis.com.au was developed by a team of clinicians in Australia and New Zealand with extensive experience in bronchiectasis. The content of this website, based on national and international guidelines, is presented under the headings: ‘Bronchiectasis’, ‘Assessment’, ‘Physiotherapy’, ‘Indigenous’, ‘Paediatrics’, and ‘Resources’. Through a blend of multimedia resources, this website provides information to consolidate the knowledge and practical skills for health professionals caring for people with this condition. After launching in 2015 the website has received 64,549 hits from over 100 countries and the videos have been viewed 10,205 times in 89 countries. The Bronchiectasis Toolbox is a comprehensive multidisciplinary resource accessible to health professionals worldwide who manage people with bronchiectasis and is a unique solution to an educational need. Regular updates will ensure that the website continues to be relevant.


  • Open Access

    Airway-Clearance Techniques in Children and Adolescents with Chronic Suppurative Lung Disease and Bronchiectasis

    by Annemarie L. Lee, Brenda M. Button, Esta-Lee Tannenbaum

    Common symptoms of chronic suppurative lung disease or bronchiectasis in children and adolescents are chronic cough with sputum production, retention of excess secretions in dilated airways and a history of recurrent infections. Clinical management includes the prescription of airway clearance techniques to facilitate mucociliary clearance, optimize sputum expectoration, relieve symptoms and improve well-being. A wide range of airway clearance techniques are available for selection and these strategies may be applied in isolation or in combination. The choice of technique will depend in part on the age of the child, their clinical state and factors which may influence treatment adherence. While the evidence base for airway clearance techniques in children and adolescent with these conditions is not robust, the current available evidence in addition to clinical expertise provides guidance for technique prescription and clinical effect. An overview of the most commonly applied airway clearance techniques, including their physiological rationale and discussion of factors influencing prescription in children and adolescents is outlined in this review.